What is AbbVie's change in AP?

AbbVie (ABBV) reported change in AP of -$1.59B in Q1 2026.

How has AbbVie's change in AP changed year-over-year?

AbbVie's change in AP decreased by 129.0% year-over-year, from -$696M to -$1.59B.

What is the long-term trend for AbbVie's change in AP?

Over 3 years (2021 to 2024), AbbVie's change in AP has grown at a -53.1% compound annual growth rate (CAGR), from $1.72B to $177M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

AbbVie ABBV Change in AP

Change in AP at other companies

Eli LillyLLY

$2.55B+290%

PfizerPFE

-$117.25M+54.2%

Johnson & JohnsonJNJ

-$3.92B-84.4%

AmgenAMGN

$571M+14.9%

Cardinal HealthCAH

$2.03B+120%

Vertex PharmaceuticalsVRTX

$35.6M+35.9%

Other financials

Income statement

See full

Revenue$15.0B+12.4%

Gross profit$10.8B+15.4%

Operating income$4.0B+6.9%

Net income$695.0M-46.0%

EPS (diluted)$0.39-45.8%

Balance sheet

See full

Cash & equivalents$9.4B+81.5%

Total debt$62.4B+1.8%

Total equity-$6.7B-569%

Total assets$136.46B+0.2%

Cash flow

See full

Operating cash flow$3.8B+134%

CapEx$265.0M+12.8%

Free cash flow$3.6B+155%

Valuation

See full

Market cap$444.6B+34.7%

P/E122.3×+34.6×

P/S7.1×+1.4×

Profitability

See full

Gross margin70.7%0.0pp

Operating margin24.4%—

Net margin5.8%-1.5pp

FCF margin31.8%+5.0pp

Returns & leverage

See full

Return on equity89%+32.7pp

Debt / equity46.6×+38.6×

Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AbbVie's change in AP?: AbbVie (ABBV) reported change in AP of -$1.59B in Q1 2026.
How has AbbVie's change in AP changed year-over-year?: AbbVie's change in AP decreased by 129.0% year-over-year, from -$696M to -$1.59B.
What is the long-term trend for AbbVie's change in AP?: Over 3 years (2021 to 2024), AbbVie's change in AP has grown at a -53.1% compound annual growth rate (CAGR), from $1.72B to $177M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.